Here's Why Clarus Therapeutics Shares Got Obliterated

By: via Benzinga
Clarus Therapeutics Holdings Inc (NASDAQ: CRXT) shares traded lower by 32.24% to $0.14 during Monday's trading session after the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.